Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
VIPR1 encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Additionally we are shipping Vasoactive Intestinal Peptide Receptor 1 Antibodies (124) and Vasoactive Intestinal Peptide Receptor 1 Kits (21) and many more products for this protein.
Showing 4 out of 6 products:
In vitro-polarized macrophages by GM-CSF (show CSF2 Proteins) (GM-MO), with a proinflammatory profile, expressed higher levels of VIP (show Vip Proteins) receptors, vasoactive intestinal polypeptide (show Vip Proteins) receptors 1 and 2 (VPAC1 and VPAC2 (show VIPR2 Proteins), respectively), than macrophages polarized by M-CSF (show CSF1 Proteins) (M-MO) with anti-inflammatory activities. RA synovial macrophages, according to their GM-CSF (show CSF2 Proteins)-like polarization state, expressed both VPAC1 and VPAC2 (show VIPR2 Proteins).
VPAC1 rs9677 CC genotype could be correlated with a reduced response to statin therapy and seems to be involved in diabetes cardiomyopathy in female patients with type 2 diabetes.
The results reveal that more severe inflammation, based on high levels of IL-6 (show IL6 Proteins), is associated with lower expression of VPAC1 and, conversely, with increased expression of VPAC2 (show VIPR2 Proteins).
variations at the 3'UTR of the VPAC-1 gene act synergistically to affect the expression of the luciferase as well as of the GFP reporter genes expressed in HEK293T cells.
These data suggest that VPAC1 overexpression is associated with poorer differentiation of colon cancer, which is likely caused by subsequent EGFR (show EGFR Proteins) activation in cancer cells.
VIP (show Vip Proteins) regulates CFTR (show CFTR Proteins) membrane expression and function in Calu (show CALU Proteins)-3 cells by increasing its interaction with NHERF1 (show SLC9A3R1 Proteins) and P-ERM (show ETV5 Proteins) in a VPAC1- and PKCepsilon (show PRKCE Proteins)-dependent manner.
VPAC1 receptor has a role in endotoxemia in peripheral blood mononuclear cells
The overexpression of VPAC1 and VPAC2 (show VIPR2 Proteins) receptors and COX-2 in cancer tissue gives them a potential role as targets for diagnosis of prostate cancer.
hree residues play an important role in VPAC1 interaction with the first histidine residue of VIP (show Vip Proteins). These data demonstrate that VIP (show Vip Proteins) and PG97-269 bind to distinct domains of VPAC1
The genetic association reported here indicates that VIP (show Vip Proteins)/VPAC1 signaling can be a relevant pathway in the pathogenesis of type 2 diabetes in females
This study demonstrated that VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
VPAC1R mRNA expression was significantly decreased 3 days after ischemia induced by bilateral common carotid artery occlusion
Cyclophosphamide-induced cystitis decreased VPAC1 receptor transcript expression in the urothelium of WT (4 h, 48 h, & chronic) & NGF (show NGFB Proteins)-OE mice.
Data support the notion that both VPAC1 and VPAC2 (show VIPR2 Proteins) receptors are dynamically regulated by Ikaros (show IKZF1 Proteins), a master transcriptional regulator for thymocyte differentiation, during early thymic development.
results support that decline in VIP (show Vip Proteins)/VPAC local levels may influence survival/apoptosis intracellular set point in NOD acinar cells and their clearance, contributing to gland homeostasis loss in a model of Sjogren's syndrome
Homozygous deletion of VPAC1 resulted in fetal, neonatal, and postweaning death owing to failure to thrive, intestinal obstruction, and hypoglycemia.
VIP (show Vip Proteins) enhancement of the severity of dextran sodium sulfate-induced colitis is mediated solely by VPAC1 receptors in mice.
Data describe PACAP (show ADCYAP1 Proteins), vasoactive intestinal polypeptide (show Vip Proteins), and PAC1 (show ADCYAP1R1 Proteins), VPAC1, VPAC2 (show VIPR2 Proteins) transcripts or protein expression in urothelium and detrusor smooth muscle and lumbosacral dorsal root ganglia in NGF (show NGFB Proteins)-overexpressing and wildtype mice.
VPAC(1)-R activation aggravates atherosclerotic lesion formation in apolipoprotein E (show APOE Proteins)-deficient mice through enhanced inflammatory activity in the vessel wall.
VIP (show Vip Proteins) and its receptors (VPAC1, VPAC2 (show VIPR2 Proteins)) were identified in type II taste cells of the taste bud, and VIP (show Vip Proteins) knockout mice exhibit enhanced taste preference to sweet tastants.
Implanting vascular bundles into the tissue engineered bone can significantly improve the expression levels of NK1R (show TACR1 Proteins) and VIPR1.
The study confirmed the presence of VPAC1 receptor in the tissues of the porcine female reproductive tract what clearly shows the possibility of influence of vasoactive intestinal polypeptide (show Vip Proteins) on the porcine ovary, oviduct and uterus.
This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. Several transcript variants encoding different isoforms have been found for this gene.
PACAP type II receptor
, VIP and PACAP receptor 1
, VIP receptor, type I
, pituitary adenylate cyclase activating polypeptide receptor, type II
, vasoactive intestinal polypeptide receptor 1
, VIP receptor subtype 1
, pituitary adenylate cyclase-activating polypeptide type II receptor
, Vasopressive intestinal peptide receptor
, vasoactive intestinal peptide receptor 1
, vasoactive intestinal polypeptide receptor 1-like
, vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor 1
, vpac1 receptor
, vasoactive intestinal polypeptide receptor type 1
, VIP receptor
, Vasoactive intestinal polypeptide receptor